EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Millennium Investment & Acquisition Company Inc (MILC) fair value: what the stock is really worth

We calculate from audited financials what Millennium Investment & Acquisition Company Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Jul 29, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · ISIN US60039Q1013

MI Millennium Investment & Acquisition Company Inc logo Thin data Jul 29, 2026

Millennium Investment & Acquisition Company Inc

MILC · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value $0.0004 · Strongly undervalued (+100.0%)
!Quality 33/100
!Weak Growth (revenue YoY −73.3 %/yr)
!Negative equity (buybacks among others) · negative free cash flow
✓Ranks above peers (3/5)
!Narrow moat 12/100
!Evidence only low, so the estimate is less certain
Watch Millennium Investment & Acquisition Company Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$10.15 $0.0001 Fair Value $0.0004 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 29, 2026.

How to read this chart

60‑month range $0.0001 – $10.15 · fair‑value band $0.0004 – $0.0004 · the $0.0002 price screens below the $0.0004 fair value. Dashed = 300-day average. As of Jul 29, 2026.

Follow Millennium Investment & Acquisition Company in your weekly email

Every Wednesday you see whether Millennium Investment & Acquisition Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Millennium Investment and Acquisition Co. Inc.

Show more

Millennium Investment and Acquisition Co. Inc. (ticker: MILC) MILC has three assets: 1) Activated Carbon ("AC") plant located in Kawaihae, Hawaii 2) SMC Global ("SMC") - India financial services firm 3) Approximately $2 million of cash and short term investments (zero debt) Investors in MILC can gain exposure to Alternative Energy and India which are two potentially appealing investment allocation sectors.

Stock analysis

Millennium Investment & Acquisition Company Inc (MILC) currently trades at $0.0002, while our model-based Fair Value estimate is $0.0004, implying the stock looks roughly 50.0% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 88/100, which puts the evidence level at low.

Scenario range: $0.0004 (bear) to $0.0004 (bull), the price of $0.0002 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Millennium Investment & Acquisition Company Inc reported revenue of $41.8K in FY2021 versus $8.5M in FY2017, a compound −73.5%/yr. Reported net income was −$7.2M in FY2021.

Key figures

Market cap $2.2K · EPS (TTM) $−0.7900 · Return on equity −1,242% · Return on assets (EBIT) −11.8% · Operating margin −5,957% · Revenue growth (YoY) +14.5% · Free cash flow −$6.0M · Net debt $40.7M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).

What moves the price

The share trades about 50% below its 52-week high and 100% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at 100%, MILC screens cheaper than that median.

Fair Value models

Bear $0.0004 Fair Value $0.0004 Bull $0.0004
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) $0.0003 $0.0004 $0.0006 54
All 1 models by family
Asset-Based
NCAV (Graham) $0.0003 $0.0004 $0.0006 54

Open the full fair value analysis →

Notify me when MILC reaches fair value

Put MILC on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 33/100

Of which business quality 33 · Market factors (momentum, volatility) 60

Profitability 0
Margins and returns on capital today
Quality Growth 9
Are margins and returns improving?
Cashflow 30
Earnings quality: real cash, not paper profit
Fin. Strength 27
Balance sheet, leverage, solvency risk
Investment 81
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 63
Price trend over the last 3–12 months (market factor)
52W Momentum 67
Distance to the 52-week high (market factor)
Net Issuance 80
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
Revenue growth 1 year
−73.3%
Revenue growth 15 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−20.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
56.8% (2016) → −11,163.8% (2021)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2021 is a loss year, no rate is defined from a loss
not computed

Watch MILC, get fair value alerts →

Compare Millennium Investment & Acquisition Company Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 599 stocks

Beats the industry median on 2/4 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 33 · Bottom 25%
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −15.3% · Bottom 25%
Growth and dividend
Revenue growth 14.5% · Above median
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM) 0.01× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 17
FUTURE (revenue growth)73 · sector 24
PAST (return on equity)0 · sector 27
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 30

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €134.45 €108.94 −19%
Takeda Pharmaceutical Company TAK $18.90 $11.45 −39%
Teva Pharmaceutical Industries Limited TEVA $39.31 $20.88 −47%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,852 ₹1,979 +7%
Galderma Group GALD CHF 163.00 CHF 110.32 −32%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥44.86 ¥49.35 +10%
Haleon plc HLN $9.26 $8.49 −8%
Sandoz Group SDZ CHF 71.16 CHF 40.32 −43%
Zoetis Inc ZTS $70.30 $110.50 +57%
Divi's Laboratories Limited DIVISLAB ₹9,620 ₹1,871 −81%

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Millennium Investment & Acquisition Company Inc Fair Value". https://www.fairvalue-calculator.com/stock/MILC

Frequently asked questions

Is Millennium Investment & Acquisition Company Inc (MILC) overvalued or undervalued?
As of Jul 29, 2026, our model estimates a fair value of $0.0004 versus a price of $0.0002, about +100% upside (undervalued).
What is the fair value of MILC?
Our model-based fair value for Millennium Investment & Acquisition Company Inc is $0.0004 (as of Jul 29, 2026), built from audited fundamentals. The current price: $0.0002.
What is the quality score of MILC?
Millennium Investment & Acquisition Company Inc has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Millennium Investment & Acquisition Company Inc (MILC)?
Our model-based price target is the fair value of $0.0004 (as of Jul 29, 2026) from 1 valuation models. Cautious scenario $0.0004, optimistic scenario $0.0004. It is a calculation from audited fundamentals, not an analyst target.
What is the Millennium Investment & Acquisition Company Inc stock forecast for 2026?
Our models put fair value at $0.0004, about +100% upside versus a price of $0.0002 (undervalued). Cautious scenario $0.0004, optimistic scenario $0.0004. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Millennium Investment & Acquisition Company Inc (MILC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Millennium Investment & Acquisition Company Inc it is $0.0004 per share (as of Jul 29, 2026), against a price of $0.0002. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Millennium Investment & Acquisition Company Inc stock overvalued or undervalued in 2026?
As of Jul 29, 2026, MILC trades below its calculated fair value: price $0.0002, fair value $0.0004, a gap of about +100% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MILC?
No. The price is what the market pays today ($0.0002); the fair value is what the company's own numbers justify ($0.0004). For Millennium Investment & Acquisition Company Inc the two are $0.0002 per share apart. That gap is exactly why we show both numbers side by side.
How much is Millennium Investment & Acquisition Company Inc worth?
The market values Millennium Investment & Acquisition Company Inc at about $2.2K (market capitalisation, as of Jul 29, 2026). Per share that is $0.0002; our models calculate a fair value of $0.0004 per share.
What do the bullish and bearish scenarios say about MILC?
Our models span a range for Millennium Investment & Acquisition Company Inc: cautious scenario $0.0004, base $0.0004, optimistic $0.0004 per share (as of Jul 29, 2026, price $0.0002). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Millennium Investment & Acquisition Company Inc (MILC)?
Balance-sheet figures for Millennium Investment & Acquisition Company Inc (as of Jul 29, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 33/100, which measures business quality independently of the share price.
How far is MILC from its 52-week high?
Millennium Investment & Acquisition Company Inc trades at $0.0002, about 50% below its 52-week high of $0.0004 and 100% above the low of $0.0001 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0004 is for.
Which stocks are comparable to Millennium Investment & Acquisition Company Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Millennium Investment & Acquisition Company Inc stock attractive at the current price?
The data as of Jul 29, 2026: price $0.0002, calculated fair value $0.0004 (+100%), Quality Score 33/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MILC calculated?
We run Millennium Investment & Acquisition Company Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0004, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Millennium Investment & Acquisition Company Inc currently trades 50 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Millennium Investment & Acquisition Company Inc (MILC)?
The closing price on Oct 1, 2026 was $0.0002. Our model-based fair value is $0.0004, about +100% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Millennium Investment & Acquisition Company Inc right now?
The large discount to fair value meets weak quality (33/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.0004). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band ($0.0004 to $0.0004), unusually little disagreement for a valuation.

Key figures of Millennium Investment & Acquisition Company Inc

How large is the market capitalisation of Millennium Investment & Acquisition Company Inc (MILC)?
The market capitalisation of Millennium Investment & Acquisition Company Inc is $2.2K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Millennium Investment & Acquisition Company Inc (MILC)?
Earnings per share at Millennium Investment & Acquisition Company Inc are $−0.7900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Millennium Investment & Acquisition Company Inc (MILC)?
The return on equity (ROE) of Millennium Investment & Acquisition Company Inc is −1,242% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Millennium Investment & Acquisition Company Inc (MILC)?
On an EBIT basis the return on assets of Millennium Investment & Acquisition Company Inc is −11.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Millennium Investment & Acquisition Company Inc (MILC)?
The operating margin of Millennium Investment & Acquisition Company Inc is −5,957% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Millennium Investment & Acquisition Company Inc (MILC)?
Revenue at Millennium Investment & Acquisition Company Inc is growing +14.5% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Millennium Investment & Acquisition Company Inc (MILC) generate?
The free cash flow of Millennium Investment & Acquisition Company Inc is −$6.0M (fiscal year 2021). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Millennium Investment & Acquisition Company Inc (MILC) carry?
The net debt of Millennium Investment & Acquisition Company Inc is $40.7M (fiscal year 2021). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Millennium Investment & Acquisition Company Inc in the live analysis

One click puts Millennium Investment & Acquisition Company Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.